IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes

IA-2A positivity is consistently associated with increased progression risk throughout the natural history of type 1 diabetes development. Individuals with single-autoantibody positivity for IA-2A have a greater risk of disease progression than those who meet stage 1 criteria but who are IA-2A<sup>-</sup>. Approaches to incorporate IA-2A<sup>+</sup> status into monitoring strategies for autoantibody-positive individuals should be considered.

Authors

Institutions

Publication Details

Journal
Diabetologia
Published
2025-02-28
DOI
https://doi.org/10.1007/s00125-025-06382-x
Citations
9
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
16.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes

Richard A. Oram, MARIA JOSE REDONDO, Emily K. Sims, Heba M. Ismail et al.
9 citations
Diabetologia
Diabetes and associated disorders
16.36
article

IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes

Richard A. Oram, MARIA JOSE REDONDO, Emily K. Sims, Heba M. Ismail, Linda Anne DiMeglio, Emanuele Bosi, Lauric Ferrat, Jay M. Sosenko, David D Cuthbertson, Carmella Evans‐Molina, Brandon M. Nathan, Laura M. Jacobsen
article en
9 citations

Abstract

IA-2A positivity is consistently associated with increased progression risk throughout the natural history of type 1 diabetes development. Individuals with single-autoantibody positivity for IA-2A have a greater risk of disease progression than those who meet stage 1 criteria but who are IA-2A<sup>-</sup>. Approaches to incorporate IA-2A<sup>+</sup> status into monitoring strategies for autoantibody-positive individuals should be considered.

DiabetologiaVol. 68(5)
University of Geneva (CH), University of Minnesota (US), University of Miami (US), Vita-Salute San Raffaele University (IT), Baylor College of Medicine (US), University of Exeter (GB), University of South Florida (US), Royal Devon & Exeter NHS Foundation Trust (GB), University of Florida (US), Richard L. Roudebush VA Medical Center (US), Texas Children's Hospital (US), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), Indiana University – Purdue University Indianapolis (US)
Doris Duke Charitable Foundation, John Templeton Foundation, Ralph W. and Grace M. Showalter Research Trust Fund, Diabetes UK, National Institute of Diabetes and Digestive and Kidney Diseases
Openalex Percentile: Top 1%
Diabetes and associated disorders
16.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.